Total Payments
$1,619
2024 Payments
$427.44
Companies
20
Transactions
78
Medicare Patients
36,671
Medicare Billing
$4.3M
Payment Breakdown by Category
Food & Beverage$1,590 (98.2%)
Education$29.00 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,590 | 76 | 98.2% |
| Education | $29.00 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Organogenesis Inc. | $357.67 | 19 | $0 (2024) |
| PFIZER INC. | $206.91 | 12 | $0 (2024) |
| Galderma Laboratories, L.P. | $195.09 | 11 | $0 (2024) |
| Aclaris Therapeutics, Inc. | $125.00 | 1 | $0 (2019) |
| GENZYME CORPORATION | $113.08 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $104.87 | 5 | $0 (2024) |
| ABBVIE INC. | $103.53 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $103.47 | 5 | $0 (2024) |
| Amgen Inc. | $48.72 | 2 | $0 (2021) |
| Dermavant Sciences, Inc. | $38.49 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $427.44 | 22 | Organogenesis Inc. ($227.68) |
| 2023 | $397.35 | 19 | Organogenesis Inc. ($106.65) |
| 2022 | $276.26 | 13 | GENZYME CORPORATION ($88.25) |
| 2021 | $61.17 | 3 | ORGANOGENESIS INC. ($23.34) |
| 2020 | $73.84 | 5 | PFIZER INC. ($26.31) |
| 2019 | $160.69 | 3 | Aclaris Therapeutics, Inc. ($125.00) |
| 2018 | $88.52 | 5 | Amgen Inc. ($26.89) |
| 2017 | $133.75 | 8 | PFIZER INC. ($46.67) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $34.79 | General |
| Category: WOUND CARE | ||||||
| 12/11/2024 | Almirall LLC | Seysara (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: WOUND CARE | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Organogenesis Inc. | PURAPLY WOUND MATRIX (Device) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: WOUND CARE | ||||||
| 11/12/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: WOUND CARE | ||||||
| 10/30/2024 | Organogenesis Inc. | PURAPLY WOUND MATRIX (Device) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: WOUND CARE | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Immunology | ||||||
| 08/07/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $29.70 | General |
| 07/12/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $29.41 | General |
| 06/27/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $5.64 | General |
| 05/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $27.39 | General |
| 05/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $4.43 | General |
| 04/10/2024 | ABBVIE INC. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: IMMUNOLOGY | ||||||
| 03/08/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $28.47 | General |
| 02/23/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $35.03 | General |
| 02/21/2024 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $19.81 | General |
| 02/01/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: DERMATOLOGY | ||||||
| 01/22/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $3.30 | General |
| 01/12/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $14.49 | General |
| 12/11/2023 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: Immunology | ||||||
| 12/08/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.43 | General |
| 12/06/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.11 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 55 | 12,332 | 23,441 | $4.3M | $1.4M |
| 2022 | 46 | 8,518 | 14,210 | $2.9M | $966,256 |
| 2021 | 46 | 8,299 | 14,074 | $3.0M | $1.0M |
| 2020 | 42 | 7,522 | 12,455 | $2.7M | $873,302 |
Total Patients
36,671
Total Services
64,180
Medicare Billing
$4.3M
Procedure Codes
189
All Medicare Procedures & Services
189 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 2,060 | 3,460 | $532,840 | $227,828 | 42.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 1,596 | 2,160 | $496,800 | $144,710 | 29.1% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 292 | 340 | $357,000 | $128,084 | 35.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 298 | 348 | $328,164 | $116,044 | 35.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,529 | 2,167 | $255,706 | $78,616 | 30.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 701 | 868 | $210,056 | $72,545 | 34.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 802 | 803 | $185,493 | $56,585 | 30.5% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 19 | 583 | $142,252 | $55,232 | 38.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 275 | 381 | $142,113 | $51,859 | 36.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 657 | 1,180 | $141,600 | $48,844 | 34.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 154 | 183 | $122,793 | $43,821 | 35.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 1,212 | 7,838 | $109,732 | $41,172 | 37.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 234 | 303 | $116,655 | $38,623 | 33.1% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 171 | 189 | $133,812 | $28,020 | 20.9% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 177 | 195 | $121,290 | $23,134 | 19.1% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 130 | 140 | $83,720 | $20,889 | 25.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 414 | 476 | $44,268 | $19,663 | 44.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 147 | 182 | $47,866 | $15,190 | 31.7% |
| 11623 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 93 | 99 | $65,736 | $12,407 | 18.9% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 39 | 40 | $35,000 | $11,820 | 33.8% |
| 13151 | Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm | Office | 2023 | 34 | 34 | $31,620 | $11,632 | 36.8% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2023 | 82 | 84 | $58,548 | $10,930 | 18.7% |
| 11644 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 3.1-4.0 cm | Office | 2023 | 58 | 60 | $52,440 | $10,877 | 20.7% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 31 | 31 | $26,381 | $10,132 | 38.4% |
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Office | 2023 | 25 | 26 | $26,000 | $9,946 | 38.3% |
About Dr. Gregory Houck, DO
Dr. Gregory Houck, DO is a Procedural Dermatology healthcare provider based in Estero, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487625885.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Houck, DO has received a total of $1,619 in payments from pharmaceutical and medical device companies, with $427.44 received in 2024. These payments were reported across 78 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,590).
As a Medicare-enrolled provider, Houck has provided services to 36,671 Medicare beneficiaries, totaling 64,180 services with total Medicare billing of $4.3M. Data is available for 4 years (2020–2023), covering 189 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Other Specialties Dermatology
- Location Estero, FL
- Active Since 02/01/2006
- Last Updated 06/10/2023
- Taxonomy Code 207NS0135X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487625885
Products in Payments
- EUCRISA (Drug) $206.91
- RHOFADE (Drug) $137.92
- Puraply (Medical Supply) $106.65
- KEYTRUDA (Biological) $103.47
- DUPIXENT (Biological) $97.42
- CYGNUS DUAL (Medical Supply) $47.73
- COSENTYX (Drug) $43.77
- VTAMA (Drug) $38.49
- LIBTAYO (Biological) $38.35
- RINVOQ (Biological) $34.55
- PURAPLY WOUND MATRIX (Device) $31.79
- Seysara (Drug) $29.64
- Bimzelx (Biological) $29.15
- Enbrel (Biological) $26.89
- VALCHLOR MECHLORETHAMINE (Drug) $24.97
- DORYX (Drug) $24.09
- Puraply Antimicrobial (Medical Supply) $23.34
- COSENTYX (Biological) $22.82
- Otezla (Drug) $21.83
- TALTZ (Drug) $21.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.